deltatrials
Completed PHASE2 INTERVENTIONAL NCT00000214

IV Cocaine Abuse: A Laboratory Model - 3

IV Cocaine Abuse: A Laboratory Model

Sponsor: Columbia University

Interventions Buprenorphine
Updated 5 times since 2017 Last updated: Aug 27, 2015 Started: Jan 31, 1992 Primary completion: Jan 31, 1993 Completion: Jan 31, 1993
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Cocaine-Related Disorders, this trial is completed. The trial is conducted by Columbia University and has accumulated 5 data snapshots since 1992. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Jan 1992

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Columbia University
  • National Institute on Drug Abuse (NIDA)
  • New York State Psychiatric Institute
Data source: New York State Psychiatric Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations